Cost-effectiveness of applying high-sensitivity troponin I to a score for cardiovascular risk prediction in asymptomatic population
Paul Jülicher(Abbott (United States)), Uwe Siebert(Harvard University), Barbara Thorand(Helmholtz Zentrum München), Simona Costanzo(Istituto Neurologico Mediterraneo), Chiara Donfrancesco, Stefan Blankenberg(Universität Hamburg), Licia Iacoviello(Istituto Neurologico Mediterraneo), Kari Kuulasmaa(Finnish Institute for Health and Welfare), Frank Kee(Queen's University Belfast), Tanja Zeller(Universität Hamburg), Nataliya Makarova(German Centre for Cardiovascular Research), Allan Linneberg(Frederiksberg Hospital), Francisco Ojeda(Universidad Complutense de Madrid), Veikko Salomaa(Finnish Institute for Health and Welfare), Isabella Giusepi(Abbott (United States)), Annette Conrads‐Frank(UMIT - Private Universität für Gesundheitswissenschaften, Medizinische Informatik und Technik), Luigi Palmieri(Istituto Superiore di Sanità), Annette Peters(Center for Environmental Health), Giancarlo Cesana(University of Milano-Bicocca), Stefan Söderberg(Umeå University), Simona Giampaoli(University of Washington), Paolo Brambilla(University of Milano-Bicocca), Torben Jørgensen(University of Copenhagen), Tarja Tuovinen(Finnish Institute for Health and Welfare), Felicity Lamrock(Queen's University Belfast)
Cited by 3
Related Papers
Richness of human gut microbiome correlates with metabolic markers
|Nature|2013|4.7k
Large-scale association analyses identify host factors influencing human gut microbiome composition
|Nature Genetics|2021|1.9k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Association of Cardiometabolic Multimorbidity With Mortality
|JAMA|2015|1.2k